Mobile ECMO in COVID-19 patient: case report.
Martínez DanielaSalech FelipeSint Jan Van NicoletteRegueira TomásVillalabeitia EliRufs JorgeFajardo ChristianCastillo RobertoIñiguez JoseDurán LuisaRodrigo DiazPublished in: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (2020)
At July 25, 2020, WHO had recorded more than 16.1 million confirmed COVID-19 cases, 1% of them developed critical illness. These patients can experience rapid progression to profound hypoxemia and severe acute respiratory distress syndrome (ARDS). Some patients, despite receiving lung-protective ventilation and maximal medical therapy, develop refractory hypoxemia, rendering candidates for extracorporeal membrane oxygenation (ECMO) support. Centers with experience in this technique are available only in a few reference hospitals and some patients are too ill to be transferred with conventional mechanical ventilation so they need mobile ECMO (interhospital transport under ECMO). Here we report the first interhospital extracorporeal membrane oxygenation transport of a COVID-19 patient in Chile, showing that it is feasible and safe to transfer a COVID-19 patient under ECMO support if a mobile ECMO program is correctly implemented and the particularities of protective measures are properly taken.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- respiratory failure
- end stage renal disease
- case report
- coronavirus disease
- sars cov
- chronic kidney disease
- newly diagnosed
- ejection fraction
- healthcare
- peritoneal dialysis
- prognostic factors
- stem cells
- intensive care unit
- blood pressure
- quality improvement
- body composition
- mesenchymal stem cells
- quantum dots
- intellectual disability
- bone marrow